Pharmaceutical Antitrust 2018

Pharmaceutical Antitrust 2018

Pages: 140

ISBN: 978-1-78915-049-0

  • £300.00

This easy-to-use reference guide provides comparative analysis and expert local insight into the field of pharmaceutical antitrust across 19 jurisdictions, covering areas such as: pharmaceutical regulatory law, competition legislation and regulation, review of mergers, anti-competitive agreements and anti-competitive unilateral conduct.

Published in April 2018, this edition contains the following chapters:

Editorial chapters

  • Introduction
    • Marta Giner Asins and Yann Anselin, Norton Rose Fulbright LLP


  • Brazil
  • Bulgaria
  • Canada
  • China
  • Finland
  • France
  • India
  • Israel
  • Japan
  • Korea
  • Mexico
  • Poland
  • Portugal
  • Romania
  • Spain
  • Turkey
  • Ukraine
  • United Kingdom
  • United States

Marta Giner Asins, Norton Rose Fulbright LLP

Marta Giner Asins, of counsel, joined Norton Rose after practising with several French and international law firms. She regularly defends clients before the French and European authorities and courts, particularly in cases of abuse of dominant position. She has also assisted clients during “dawn raids” conducted by competition authorities and in the procedures challenging such inspections. She has been involved in several French and European merger cases, among which several multi-jurisdictional filings. Marta regularly organises internal training sessions for clients on the main aspects of competition law.

Yann Anselin, Norton Rose Fulbright LLP

We Also Recommend